Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. aap Implantate AG's Revenue for the
six
months ended in Dec. 2025 was €6.26 Mil. aap Implantate AG's average Accounts Receivable for the
six
months ended in Dec. 2025 was €2.44 Mil.
Hence, aap Implantate AG's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.57.
aap Implantate AG (CHIX:AAQ1d) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
aap Implantate AG Receivables Turnover Related Terms
aap Implantate AG Receivables Turnover Historical Data
* Premium members only.
The historical data trend for aap Implantate AG's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AAQ1D vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, aap Implantate AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aap Implantate AG Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where aap Implantate AG's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aap Implantate AG (CHIX:AAQ1D) has a Receivables Turnover of 2.57 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on aap Implantate AG and its competitors. According to the industry distribution chart, aap Implantate AG ranks #414 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 50.9%.
Is aap Implantate AG's Receivables Turnover too high?
aap Implantate AG's current Receivables Turnover is 2.57. The Medical Devices & Instruments industry median Receivables Turnover is 5.60. aap Implantate AG's value of 2.57 is 54.1% below this industry median. Based on the distribution chart, aap Implantate AG ranks #414 out of 813 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, aap Implantate AG has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, aap Implantate AG ranks #414 out of 813 companies for Receivables Turnover. This places aap Implantate AG in the lower half of its industry. The industry median Receivables Turnover is 5.60. aap Implantate AG's value of 2.57 is 54.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.60, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. aap Implantate AG's current Receivables Turnover of 2.57 is 54.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on aap Implantate AG and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aap Implantate AG's current Receivables Turnover is 2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
aap Implantate AG (CHIX:AAQ1D) has a current Receivables Turnover of 2.57. The stock's GF Value™ is €1.95, compared to a current price of €3.15 — trading 61.3% above its estimated fair value. The current Receivables Turnover is 2.57 and 54.1% below the Medical Devices & Instruments industry median of 5.60. aap Implantate AG's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For aap Implantate AG (CHIX:AAQ1D), the current Receivables Turnover is 2.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aap Implantate AG (CHIX:AAQ1D) Overvalued in 2026?
Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued.
The current stock price of €3.15 is trading 61.3% above its estimated GF Value™ of €1.95.
Key valuation signals for CHIX:AAQ1D:
Receivables Turnover: 2.57
GF Value™: €1.95 vs. price of €3.15 (61.3% above fair value)
Industry Position: 54.1% below the Medical Devices & Instruments median (#414 of 813)
No single metric tells the full story. See the CHIX:AAQ1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
42GF Score
Get the complete analysis for CHIX:AAQ1D
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AAQ1D has been successfully added to your 
